Interactome Analysis Identifies MSMEI_3879 as a Substrate of Mycolicibacterium smegmatis ClpC1

• Published in: Microbiology spectrum Vol. 11; no. 4; p. e0454822
• Main Authors: Ogbonna, Emmanuel C, Anderson, Henry R, Beardslee, Patrick C, Bheemreddy, Priyanka, Schmitz, Karl R
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 17.08.2023
• Subjects: Anti-Bacterial Agents - pharmacology; Bacterial Proteins - metabolism; Clp protease; Heat-Shock Proteins - genetics; Humans; interactome; Molecular Chaperones - metabolism; Mycobacterium; Mycobacterium smegmatis - metabolism; Mycobacterium tuberculosis; proteolysis; proteomics; Tuberculosis - microbiology; Clp protease; Mycobacterium; interactome; proteomics; proteolysis
• ISSN: 2165-0497; 2165-0497
• DOI: 10.1128/spectrum.04548-22

The prevalence of drug-resistant Mycobacterium tuberculosis infections has prompted extensive efforts to exploit new drug targets in this globally important pathogen. ClpC1, the unfoldase component of the essential ClpC1P1P2 protease, has emerged as one particularly promising antibacterial target. However, efforts to identify and characterize compounds that impinge on ClpC1 activity are constrained by our limited knowledge of Clp protease function and regulation. To expand our understanding of ClpC1 physiology, we employed a coimmunoprecipitation and mass spectrometry workflow to identify proteins that interact with ClpC1 in Mycolicibacterium smegmatis, a surrogate for M. tuberculosis. We identify a diverse panel of interaction partners, many of which coimmunoprecipitate with both the regulatory N-terminal domain and the ATPase core of ClpC1. Notably, our interactome analysis establishes MSMEI_3879, a truncated gene product unique to M. smegmatis, as a novel proteolytic substrate. Degradation of MSMEI_3879 by ClpC1P1P2 requires exposure of its N-terminal sequence, reinforcing the idea that ClpC1 selectively recognizes disordered motifs on substrates. Fluorescent substrates incorporating MSMEI_3879 may be useful in screening for novel ClpC1-targeting antibiotics to help address the challenge of M. tuberculosis drug resistance. Drug-resistant tuberculosis infections are a major challenge to global public health. Much effort has been invested in identifying new drug targets in the causative pathogen, Mycobacterium tuberculosis. One such target is the ClpC1 unfoldase. Compounds have been identified that kill M. tuberculosis by disrupting ClpC1 activity, yet the physiological function of ClpC1 in cells has remained poorly defined. Here, we identify interaction partners of ClpC1 in a model mycobacterium. By building a broader understanding of the role of this prospective drug target, we can more effectively develop compounds that inhibit its essential cellular activities.